Newsbenzinga
Cadrenal Therapeutics Appoints John P. Sharp As Interim CFO Effective June 25, 2026; Quang X. Pham Ceases To Serve As Interim CFO
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…